Cryotherapy versus salicylic acid for the treatment of verrucae: a randomised controlled trial. - EVerT
- Conditions
- Verrucae
- Registration Number
- EUCTR2004-000905-24-IE
- Lead Sponsor
- niversity of York
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 266
Patients will be eligible if all of the following criteria apply:
The patient has a verruca that in the opinion of the health care professional is suitable for treatment with both salicylic acid and cryotherapy.
Patients are aged 12 years and over.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Patients will be excluded if any of the following criteria apply:
• Are currently in a trial evaluating other treatments for their verruca
• Have impaired healing eg due to diabetes, peripheral vascular disease or any other condition which means the patient has impaired healing
• Patients that are immunosuppressed eg have agammaglobulinaemia, or are currently taking immunosuppressant drugs such as oral corticosteroids
• Are unable to give informed consent
• Are currently on renal dialysis
Have cold intolerance eg Raynaud's syndrome or cold urticaria
•Have any of the following conditions - blood dyscrasias of unknown origin, cryoglobulinaemia, cryofibrinogenaemia, collagen and auto-immune disease
•Patients with neuropathy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method